HTG to Spend $16M in New Financing to Develop Tests, Hire More Staff

HTG aims to boost adoption of its multiplex gene expression-testing platform in three business areas: molecular testing for translational medicine, pharmaceutical clinical development, and clinical pathology diagnostics.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.